Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07709897 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Clinical Trial of HRS5580 for Injection Combined With Palonosetron Hydrochloride for the Prevention of Postoperative Nausea and Vomiting

StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Recruitment opened Trial arms changed: 4 → 3 · Start date changed from estimate of Jul 2026 to Aug 6, 2026 · Interventions: HRS5580 for injection blank preparation combined with palonosetron hydrochloride (Drug), HRS5580 for injection combined with palonosetron… to HRS5580 for injection blank preparation combined with palonosetron hydrochloride (Drug), HRS5580 for injection combined with palonosetron… · 1 morev2 Show 4 more changesShow less
    • Trial arms changed: 4 → 3
    • Start date changed from estimate of Jul 2026 to Aug 6, 2026
    • Interventions: HRS5580 for injection blank preparation combined with palonosetron hydrochloride (Drug), HRS5580 for injection combined with palonosetron… to HRS5580 for injection blank preparation combined with palonosetron hydrochloride (Drug), HRS5580 for injection combined with palonosetron…
    • Site details revised at 2 of 2 sites
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The study is being conducted to evaluate the efficacy of HRS5580 for injection combined with palonosetron hydrochloride in the prevention of postoperative nausea and vomiting, and to explore the effective dose of HRS5580 for injection combined with palonosetron hydrochloride for the prevention of postoperative nausea and vomiting.
Trial Details
NCT Number NCT07709897
Lead Sponsor Fujian Shengdi Pharmaceutical Co., Ltd.
Conditions Prevention of Postoperative Nausea and Vomiting
Enrollment 260 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov